References
- Sakai R. I., Lattin J. E. Lidocaine ingestion. Am. J. Lis. Child 1980; 134: 323
- Rotnstein P., Dornbusch J., Snaywitz E. A. Prolonged seizures associated with the use of viscous lidocaine. J. Pediatr. 1982; 101: 461
- Mortenson H. C., Caraccio T. R., Miller H., et al. Lidocaine toxicity from topical mucosal application. Clin. Pediatr. 1983; 22: 190
- Evans W. E., Schentag J. J., Jusko W. J. Applied Pharmacokinetics(1st Edition). Applied Tnerapeutics Inc., San Francisco, California 1980; 354
- Boyes R. N., Scott D. D., Jepson P. J., et al. Pharmacokinetics of lidocaine in man. Clin. Pharmacol. Therap. 1971; 12: 105
- Rowland M., Thomson P. D., Guichard A., et al. Disposition kinetics of lidocaine in normal subjects. Ann. N. Y. Acad. Sci. 1971; 179: 383
- Nations R. L., Triggs T. J., Selig M. Lignocaine kinetics in cardiac patients and aged subjects. Brit. J. Clin. Pharmacol. 1977; 4: 439
- Freedman R. D., Gal J., Freed C. R. Extracorporeal pump assistance - novel treatment for acute lidocaine poisoning. Eur. J. Clin. Pharmacol 1982; 22: 129
- Gilman A. G., Goodman L. S., Gilman A. The Pharmacologic Easis of Therapeutics(6th Edition). Eacmillan Publishing Co., Inc. 1980; 781
- Narang P. K., Croutnamel W. G., Carliner N. H., et al. Lidocaine and its active metabolites. Clin. Pharm. Ther. 1978; 24: 654
- Halkin H., Eeffin P., Melmon K. L., et al. Influence of congestive heart failure on blood levels of lidocaine and its active monode-ethylated metabolite. Clin. Pharm. Ther. 1975; 17: 669
- Eurney R. G., DiFazio C. A., Foster J. A. Effect of ph on protein binding of lidocaine. Anesth. Analg. 1978; 57: 478
- Williams R. L., Mamelok R. D. Hepatic disease and drug pharmacokinetics. Clin. Pharmacokinet. 1980; 5: 528–547
- Jacobi J., McGory R. W., McCoy H., et al. Hemodialysis clearance of total unbound lidocaine. Clin. Pharm. 1983; 2: 54